G.R. No. 185894 AUGUST 30, 2017
BELO MEDICAL GROUP, INC., PETITIONER, VS. JOSE L. SANTOS AND VICTORIA G. BELO, RESPONDENTS.

FACTS

Belo Medical Group, Inc. filed a Complaint for Interpleader and a Supplemental Complaint for Declaratory Relief against its stockholders, Jose L. Santos and Victoria G. Belo. The dispute arose when Santos, a registered stockholder, demanded to inspect corporate books. Belo contested this, asserting that the shares under Santos’s name were held in trust for her, as she had paid for them, and that Santos had no ownership rights. She further alleged Santos operated a competing business, The Obagi Skin Health, Inc., making his inspection request in bad faith to obtain competitor information. Faced with these conflicting claims over share ownership and the concomitant right of inspection, Belo Medical Group initiated the interpleader suit to compel the parties to litigate their claims and sought declaratory relief to clarify its right to deny inspection under the Corporation Code.
The Regional Trial Court (RTC), a special commercial court, granted Santos’s Motion to Dismiss. The RTC ruled the complaint was an improper interpleader because Belo Medical Group was not an innocent stakeholder; it had already taken a position by siding with Belo and denying Santos’s requests. The RTC also found the action for declaratory relief inappropriate, as a judicial declaration was unnecessary given the existence of an actual controversy ripe for adjudication under an ordinary civil action. Belo Medical Group elevated the case to the Supreme Court via a Petition for Review on Certiorari.

ISSUE

Whether the Regional Trial Court correctly dismissed the Complaint for Interpleader and Supplemental Complaint for Declaratory Relief.

RULING

Yes, the Supreme Court affirmed the RTC’s dismissal. For an interpleader under Rule 62 to be proper, the plaintiff must be a mere stakeholder with no interest in the subject matter and must not have incurred independent liability to any claimant. Here, Belo Medical Group failed this test. It was not a disinterested party; it had actively taken sides by denying Santos’s inspection requests based on Belo’s allegations and its own assessment of Santos’s competitive business interests. By alleging Santos’s bad faith and his ownership of a rival company, the corporation asserted its own substantive defenses, thereby transforming itself from a passive stakeholder into an active litigant with an interest in the outcome. This active alignment with one claimant disqualifies it from using the interpleader remedy.
Regarding the action for declaratory relief, the Court ruled it was likewise improper. A declaratory relief action presupposes that no breach of an instrument or statute has occurred and seeks to clarify rights before any violation. The situation here had progressed beyond that stage. Santos had made repeated, formal demands for inspection which Belo Medical Group had expressly and repeatedly refused. This refusal constituted an actual breach or violation of Santos’s alleged statutory right under the Corporation Code, giving rise to a direct cause of action for specific performance or damages. Consequently, the remedy was an ordinary civil action to resolve the concrete dispute over the denied inspection, not a declaratory action to speculate on future rights. The Court emphasized that the commercial nature of the RTC did not automatically make the dispute intra-corporate; the core issues were the propriety of the chosen remedies, which the RTC correctly assessed as infirm.